The U.S. Food and Drug Administration (FDA) has issued warning letters to seven online retailers on November 11th for selling unauthorized e-cigarette products. These letters accuse them of selling popular and appealing disposable e-cigarette products to young people, such as Elf Bar, EB Design, Bang, Cali Bars, and Lava brands.
The FDA stated that these warning letters were issued based on its ongoing monitoring of multiple surveillance systems to identify products that are popular or appealing among young people.
According to the results of the National Youth Tobacco Survey for 2023, more than half of current youth e-cigarette users reported using the disposable e-cigarette brand Elf Bar. Earlier this year, the manufacturer of Elf Bar began promoting the product under the brand "EB Design." Moreover, after reviewing retail sales data and emerging internal data from youth surveys, the FDA identified the brands Bang, Cali Bars, and Lava as popular or appealing to young people.
Dr. Brian King, Director of the FDA's Center for Tobacco Products, stated:
The FDA's strengthened monitoring of the e-cigarette industry helps us identify products that appeal to young people and take prompt action to protect public health. The goal is to identify, prevent, and reduce the risks posed to our youth by these products before they escalate further.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
